Key result
Modified HeartWare HVAD delivers up to ~7 L/min for right ventricular support in vitro.
Why the study?
A method to use the HeartWare HVAD LVAD for right ventricular assistance with appropriate modifications was developed and evaluated in vitro.
Can the HeartWare HVAD be modified for use as a right ventricular assist device in an in vitro model?
Can the HeartWare HVAD be modified for use as a right ventricular assist device in an in vitro model?
The HeartWare LVAD can potentially be used as a right ventricular assist device with specific modifications to the outflow graft and inflow cannula.
Modifications enable target flows in vitro; hypothesis-generating for HVAD as RVAD, requiring in vivo validation before clinical consideration.
We have developed a method that allows the use of a commercially available implantable left ventricular assist device (LVAD; HeartWare HVAD) for right ventricular (RV) assistance. A mock circulation was used to examine the flow characteristics of the system with different outflow diameters (10-4 mm). Furthermore, we looked for a material for safe and satisfactory reduction of the effective length of the inflow cannula for better fitting to the RV dimensions. Reduction of the outflow graft to an inner diameter of ∼5 mm adds as much resistance to the system that in patients with a normal pulmonary resistance, the pump would deliver between 3.5 and 7 L/min. We added two 5 mm silicon suture rings to the system's "apical" sewing ring to reduce the effective length of the inflow cannula. Connection of the pump to the anterior free wall of the right ventricle ensures good orientation of the inflow cannula within the RV cavity, with sufficient space to prevent the inflow cannula from suction to the opposite interventricular septum. The HeartWare LVAD pump seems also to be usable as a right ventricular assist device (RVAD) after a few, but important, modifications of the implant procedure.
No takes yet. Share an insight, caveat, or question.
Krabatsch et al. (2011) studied Right ventricular assistance (in vitro model). HeartWare HVAD Centrifugal Pump modified for right ventricular assistance was evaluated on Flow characteristics and pump delivery. Modification of the HeartWare HVAD outflow graft to ~5 mm inner diameter and reduction of inflow cannula length allowed the pump to deliver 3.5 to 7 L/min in an in vitro model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: